Catch up on stories from the past week (and beyond) at the Slashdot story archive


Forgot your password?
Check out the new SourceForge HTML5 internet speed test! No Flash necessary and runs on all devices. ×

Comment Re:So? (Score 1) 751

That assumes dividends reinvested and no taxes paid (all money in a tax free vehicle like a 401k). What do you intend to live on?

Trump's siblings surely got 40-200m as well, why aren't they billionaires? What makes you think you can out invest them?

More likely, assuming you are just like most everyone else, you would panic during the recessions of the 80s, the 2000 crash, and 2008 crash, and would severely underperform the market.

And Trump would still outperform you even if everything went your way.

Comment Re:So? (Score 1) 751

People who repeat this either don't pay attention or are financially illiterate.

Maybe if you froze himself in a cryogenic freezer so you never had to spend any of the dividends or cash something out of the index and cherry picked the exact time frame to allow 40-200m (depending on what source you want to use) to grow into 1 billion, then yes you can make that argument. You would still vastly underperform Trump.

If making a billion from the inheritance was so simple, why aren't any of Trump's siblings billionaires?

Comment Read the claims (Score 1) 152

1. A studio arrangement, comprising: a background comprising a white cyclorama; a front light source positioned in a longitudinal axis intersecting the background, the longitudinal axis further being substantially perpendicular to a surface of the white cyclorama; an image capture position located between the background and the front light source in the longitudinal axis, the image capture position comprising at least one image capture device equipped with an eighty-five millimeter lens, the at least one image capture device further configured with an ISO setting of about three hundred twenty and an f-stop value of about 5.6; an elevated platform positioned between the image capture position and the background in the longitudinal axis, the front light source being directed toward a subject on the elevated platform; a first rear light source aimed at the background and positioned between the elevated platform and the background in the longitudinal axis, the first rear light source positioned below a top surface of the elevated platform and oriented at an upward angle relative to a floor level; a second rear light source aimed at the background and positioned between the elevated platform and the background in the longitudinal axis, the second rear light source positioned above the top surface of the elevated platform and oriented at a downward angle relative to the floor level; a third rear light source aimed at the background and positioned in a lateral axis intersecting the elevated platform and being substantially perpendicular to the longitudinal axis, the third rear light source further positioned adjacent to a side of the elevated platform; and a fourth rear light source aimed at the background and positioned in the lateral axis adjacent to an opposing side of the elevated platform relative to the third rear light source; wherein a top surface of the elevated platform reflects light emanating from the background such that the elevated platform appears white and a rear edge of the elevated platform is substantially imperceptible to the image capture device; and the first rear light source, the second rear light source, the third rear light source, and the fourth rear light source comprise a combined intensity greater than the front light source according to about a 10:3 ratio.

If you did all that, then yes, Amazon should sue you.

Comment Re:Name Your Poison (Score 1) 698

The reason the rest of the world is cheaper is because their health care systems are subsidized by US taxpayers, US pharmas, and US medical device makers.

US Pharms do the R+D, operations, marketing and manufacturing that US investors and taxpayers pay for and then the rest of the world gets all the benefits at a lower cost per pill/treatment

Merck, Pfizer, BMY-Squibb, Lilly, JNJ, Abbott, Watson, Mylan, Gilead Sciences, etc. are all US based companies. There are almost no equivalents in the rest of the world. For example, drug development is almost completely dead in Europe except for the Swiss (Roche), and the lone ~2 remaining UK players.

Same thing goes for medical devices: JNJ, GE, BSX, MDT, STJ, EW, BCR, EK, et al. [Siemens being the main exception.]

As it stands, the rest of the world only pays the variable costs of all the research, drugs, and new products invented in the US after being subsidized by US taxpayers, gov't, and investors, essentially behaving as free-riders.

There are numerous academic studies demonstrating this, as well as the market itself showing how simple it is, for example, to make a profit re-importing the same drug from Canada *back* to the US.

What will be very interesting is the effect of a health care system like the affordable care act on the US. The reason other countries get to free-ride is because the US pays so much. If the US tries to change that then house of cards comes crashing down, and either the quality of medical care will go down all across the board, or the medical costs of the rest of the world will escalate.

Comment Even worse for shogi (Score 1) 183

Didn't mean to post this as AC:

The difference between men and women is even more drastic in Shogi (Japanese chess).

In order to qualify to become a professional, first you have to enter the Shoreikai and climb all the way to 3-dan (equivalent is amateur 6-dan) before entering a round robin tournament exam against all of the other 3-dan players. The top two get crowned as 4-dan and get to become professionals.

No woman has ever advanced past Shoreikai 1-kyu (amateur 4 dan). Hence, the shogi association created a separate womens league. The titleholders of the womens league are even seeded in the regular championship league, but they almost always lose horribly, and they can almost never beat even the newly crowned 4-dan pros (they have something like a 20% win percentage against male professionals as a whole).


Music DRM in Critical Condition? 377

ianare writes "Universal Music Group, the largest music company on the planet, has announced that the company is going to sell DRM-free music. The test will see UMG offering a portion of its catalog — primarily its most popular content — sold without DRM between August 21 and January 31 of next year. The format will be MP3, and songs will sell for 99 each, with the bitrate to be determined by the stores in question. RealNetwork's Rhapsody service will offer 256kbps tracks, the company said in a separate statement. January 31 is likely more of a fire escape than an end date. If UMG doesn't like what they're seeing, they'll pull the plug. UMG says that it wants to watch how DRM-free music affects piracy rates."

Slashdot Top Deals

The superior man understands what is right; the inferior man understands what will sell. -- Confucius